Tela Bio Inc (TELA)

Currency in USD
1.710
-0.030(-1.72%)
Real-time Data·
TELA Scorecard
Full Analysis
Quickly burning through cash
TELA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.6601.797
52 wk Range
0.8653.260
Key Statistics
Prev. Close
1.74
Open
1.71
Day's Range
1.66-1.797
52 wk Range
0.865-3.26
Volume
51.98K
Average Volume (3m)
115.93K
1-Year Change
-43.32%
Book Value / Share
0.23
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TELA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.400
Upside
+215.79%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period

Tela Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Tela Bio Inc Company Profile

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Tela Bio Inc SWOT Analysis


Biologic Innovation
Explore TELA Bio's pioneering OviTex mesh for hernia repair, offering biocompatibility and cost-effectiveness over traditional plastic alternatives
Market Dynamics
Delve into TELA Bio's position amidst the industry shift from plastic to biologic mesh, and its potential for significant market share gains
Financial Outlook
Learn about TELA Bio's revenue projections, with analyst estimates ranging from $105.5 million to $115 million for 2026, despite current profitability challenges
Strategic Challenges
Uncover TELA Bio's response to aggressive competitor tactics, including sales force refinements and a $5-10 million cost reduction plan for 2025
Read full SWOT analysis

Tela Bio Inc Earnings Call Summary for Q2/2025

  • Q2 revenue grew 26% YoY to $20.2M, despite missing forecasts; EPS of -$0.22 fell short of -$0.18 estimate
  • Stock rose 7.56% in aftermarket trading to $1.85, driven by strong product performance and improved gross margin of 69.8%
  • Company maintains FY2025 revenue guidance of $85-$88M, expecting 23-27% growth with back-weighted Q4 revenue
  • Focus on expanding OviTex PRS and Liquefix product lines; emphasis on physician engagement and education initiatives
  • Analysts set price targets from $2 to $7; TELA trading below fair value despite ongoing net losses and negative EPS outlook
Last Updated: 11/08/2025, 22:20
Read Full Transcript

Compare TELA to Peers and Sector

Metrics to compare
TELA
Peers
Sector
Relationship
P/E Ratio
−1.7x−3.6x−0.6x
PEG Ratio
−0.04−0.190.00
Price/Book
7.4x2.8x2.6x
Price / LTM Sales
0.9x3.5x3.3x
Upside (Analyst Target)
233.9%19.7%40.1%
Fair Value Upside
Unlock13.9%5.3%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.400
(+215.79% Upside)

Earnings

Latest Release
Aug 11, 2025
EPS / Forecast
-0.22 / -0.18
Revenue / Forecast
20.20M / 20.67M
EPS Revisions
Last 90 days

TELA Income Statement

People Also Watch

20.30
SRPT
+0.59%
2.830
IPA
+10.13%
3.940
ATAI
-0.76%
2.0600
DARE
+1.98%
3.210
MBOT
+3.88%

FAQ

What Stock Exchange Does Tela Bio Trade On?

Tela Bio is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tela Bio?

The stock symbol for Tela Bio is "TELA."

What Is the Tela Bio Market Cap?

As of today, Tela Bio market cap is 67.74M.

What Is Tela Bio's Earnings Per Share (TTM)?

The Tela Bio EPS (TTM) is -1.05.

When Is the Next Tela Bio Earnings Date?

Tela Bio will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is TELA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Tela Bio Stock Split?

Tela Bio has split 0 times.

How Many Employees Does Tela Bio Have?

Tela Bio has 209 employees.

What is the current trading status of Tela Bio (TELA)?

As of 20 Aug 2025, Tela Bio (TELA) is trading at a price of 1.71, with a previous close of 1.74. The stock has fluctuated within a day range of 1.66 to 1.80, while its 52-week range spans from 0.87 to 3.26.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.